Prosecution Insights
Last updated: October 01, 2026
Application No. 18/266,111

Computational Method and System for Compression of Genetic Information

Non-Final OA §101§103
Filed
Jun 08, 2023
Priority
Dec 10, 2020 — provisional 63/123,884 +2 more
Examiner
LIN, JERRY
Art Unit
Tech Center
Assignee
The Regents of the University of California
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
7m
Est. Remaining
87%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
607 granted / 840 resolved
+12.3% vs TC avg
Moderate +15% lift
Without
With
+14.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
33 currently pending
Career history
858
Total Applications
across all art units

Statute-Specific Performance

§101
33.3%
-6.7% vs TC avg
§103
20.6%
-19.4% vs TC avg
§102
14.4%
-25.6% vs TC avg
§112
20.4%
-19.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 840 resolved cases

Office Action

§101 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims Claims 1-24 are under examination. Claim Rejections - 35 USC § 101 2. 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-24 rejected under 35 U.S.C. 101 because the claimed invention is directed to judicial exception without significantly more. Claims 1-24 are directed to method and system of compressing genetic information in multiple reading frames. As described in Alice Corp. Pty. Ltd. V. CLS Bank Int’l, 573 U.S._, 134 S. Cr. 2347, 110 U.S.P.Q.2d 1976 (2014), a two-step analysis is required in considering the patent eligibility of the claimed subject matter. The first step requires determining if the claimed subject matter is directed to a judicial exception. The instant claims require the steps of encoding a first genetic sequences in computer readable data structures comprising first directed acyclic graphs (DAGs) of first finite automatons (FAs); encoding in a second DAG or second FA, overlapping sequences between the encoded first genetic sequence; calculating for each edge in the second DAG or the second FA a second score; and selecting a sequence represented by a path through the second DAG or second FA. These steps are drawn to either a mathematical algorithm or mental steps. Dependent claims 2-22 recite additional mental steps or mathematical steps. Instant claim 24 also recites the steps of a first routine to generate DAGs or FAs from protein mutation data; a second routine to create overlap DAGs or FAs using as input a series of DAGs or FAs output by the first routine; a third routine to evaluate an overlap DAG or FA to locate the best paths through DAG or FA and to alter edge weights according to specific criteria or stochastically before generate new best paths through the DG or FA; and a fourth routine to score and optimize the best paths. These steps are also drawn to mental steps or mathematical steps. Mental steps are a judicial exception. The courts have found mathematical algorithms to be drawn to the judicial exception of an abstract idea (In re Grams, 888 F.2d 835, 12 U.S.P.Q.2d 1824 (Fed. Cir. 1989)). Thus, the instant claims are drawn to a judicial exception. This judicial exception is not integrated into a practical application. The instant claims do not recite an element that reflects an improvement in the functioning of a computer or other technology, an element that applies the judicial exception to effect a particular treatment, an element that implements the judicial exception with a particular machine, or an element that effects a transformation of a particular article to a different state or thing. The instant claims recite the elements of a system, a computer processor, and memory. However, the instant claims to not recite structural limitations of these elements. The instant claims do not recite a particular machine. The instant claims do not integrate the judicial exception into a practical application. The second part of the analysis requires determining if the claims include additional elements that are sufficient to amount to significantly more than the judicial exception. The instant claims recite the additional elements of a system, a computer processor, and memory. However, these elements are well-understood, conventional and routine computer components (Specification, paragraph [0045]). Reciting such well-understood, routine, and conventional components do not transform a judicial exception into patent eligible subject matter. In addition, the recitation of the specific types of data to be used in the judicial exception does not transform the abstract idea into a non-abstract idea. (See buySAFE, Inc. v Google, Inc. 765 F.3d 1350, 112 U.S.P.Q.2d 1093 (Fed.Cir.2014)). Furthermore, the elements taken as a combination are also well-understood, routine, and conventional, since the elements are merely specifying a computer system for implementing the judicial exception. Thus, the instant claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. Claim Rejections - 35 USC § 103 3. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-6 and 23-24 are rejected under 35 U.S.C. 103 as being unpatentable over Semenyuk (US 2018/0089369 A1) in view of Chin et al. (US 2014/0025312 A1). Regarding claims 1 and 23, Semenyuk teaches a method and system that includes for a series of first genetic sequence encoding first proteins or nucleic acid sequences, associating a first score with each possible nucleotide or amino acid residue, insertion and deletion at each position (paragraph [0116]-[0120], [0148]-[0151], [0164], [0176]-[0178]); encoding the first genetic sequences in first computer-readable data structures comprising first directed acyclic graphs (DAGs) or a first finite automations (FAs) such that (i) a plurality of potential genetic sequences for the first proteins or nucleic acids sequences are encoded in the first data structures (paragraphs [0120]-[0124], [0140]-[0142]); each edge in the DAGs or first FAs represents a nucleotide residue, insertion, or deletion at that position and the first score associated with the nucleotide residue, insertion or deletion at that position (iii) each path through the first DAGs or accepted sequence in the first FAs represents a potential sequence encoding one of the first proteins or nucleic acid sequences (paragraphs [0090]-[0092] and [0117]-[0120]). In addition Semenyuk teaches that their method is implemented on a computer with a processor and memory (paragraphs [0074]-[0077]). However, Semenyuk does not teach the step of (iv) for each path through one of the first DAGs or accepted sequence in one of the first FAs, a first aggregate score of the path or accepted sequence is the accumulation of the first score of all edges along the path or accepted sequence. Chin et al. teach (iv) for each path through one of the first DAGs or accepted sequence in one of the first FAs, a first aggregate score of the path or accepted sequence is the accumulation of the first score of all edges along the path or accepted sequence (paragraph [0131]-[0134], [0149]-[0152]); encoding in the second DAG or second FA, overlapping sequence between the encoded first genetic sequences for the first proteins or nucleic acid sequences (paragraphs [0015], [0092], [0106]-[0109], [0119]-[0122], and [0129]); calculating, for each edge in the second DAG or the second FA, a second score representing a combined total effect of the component edges of the first data structures (paragraphs [0131]-[0133] and [0151]-[0153]); selecting according to the scores of each edge in the second DAG or second FA, a sequence represented by a path through the second DAG or the second FA (paragraphs [0131]-[0133] and [0157]-[0159]). Regarding claim 2, Semenyuk teaches each score reflects a likelihood of the inclusion of the particular nucleotide residue, a particular insertion, or a particular deletion at the corresponding position (paragraphs [0055]-[0058]. [0117]-[0120], [0158]-[0161] and [0164]). Regarding claim 3, Semenyuk teaches each score reflects a fitness metric associated with the inclusion of a particular nucleotide residue, or a particular insertion, or a particular deletion at the corresponding position (paragraph [0158]-[0161]). Regarding claim 4, Semenyuk teaches each score reflects an expression of the probability of the inclusion of a particular nucleotide residue, a particular insertion, or a particular deletion at the corresponding position (paragraph [0055]-[0058], [0117]-[0120], [0158]-[0161], [0164]). Regarding claim 5, Chin et al. teach each score reflects an expression of the probability of the inclusion of a particular nucleotide residue, a particular insertion, or a particular deletion at the corresponding position (paragraph [0068], [0073], [0131]-[0134]). Regarding claim 6, Semenyuk teaches encoding, the second DAG or the second FA, overlapping sequence between the encoded genetic sequence for the first proteins or nucleic acid sequences comprises: selecting, in each of the first data structures, a starting position for each data structure, the starting positions each having an edge representing the same nucleotide residue or an insertion or deletion (paragraphs [0095]-[0097], [0110]-[011], and [0117]). Chin et al. teach starting at the starting positions, adding to the second DAG or the second FA an edge each time the transitions between successive nodes in each of the first data structures includes at least one overlapping nucleotide residue or an insertion or deletion, the added edge corresponding to the at least one overlapping nucleotide residue or an insertion or deletion (paragraphs [0054]-[0058], [0094], [0129]). Regarding claim 24, Semenyuk teaches a system comprising a computer processor and a memory communicatively coupled to the computer processor, the memory storing data and instructions executable by the computer processor, the data and instructions comprising (paragraphs [0014]-[0015], [0074]-[0077]); a first routine operable to cause the computer processor to generate directed acyclic graphs (DAGs) or finite automatons (FAs) from protein mutation data (paragraphs [0120]-[0124], [0140]-[0142]); However, Semenyuk does not teach a second routine operable to cause the computer processor to create overlap DAGs or FAs using as input a series of DAGs or FAs output by the first routine. Chin et al. teach a second routine operable to cause the computer processor to create overlap DAGs or FAs using as input a series of DAGs or FAs output by the first routine (paragraphs [0015], [0092], [0106]-[0109], [0119]-[0122], [0129]); a third routine operable to cause the computer to evaluate an overlap DAG or FA to locate best paths through the DAG or FA and to alter edge weights according to specific criteria or stochastically before generating new best paths through DAG or FA (paragraphs [0131]-[0133] and [0157]-[0159]); and a fourth routine operable to cause the computer to score and optimize the best path according to non-local effects or higher-order interactions (paragraphs [0156]-[0158]. It would have been obvious to one of ordinary skill in the art, at the time of filing, to combine the references of Semenyuk and Chin et al. Semenyuk teaches a method of compressing genomic data (abstract). One of ordinary skill in the art would have been motivated to used Semenyuk’s compressed data in the method taught by Chin et al to reduce the amount of linear sequences required to encode a set of genetic elements. Furthermore, one of ordinary skill in the art would have had a reasonable expectation of success since the data of Semenyuk may be readily used in the system of Chin et al. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to JERRY LIN whose telephone number is (571)272-2561. The examiner can normally be reached T-F 7am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Olivia Wise can be reached at (571) 272-2249. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JERRY LIN/Primary Examiner, Art Unit 1685
Read full office action

Prosecution Timeline

Jun 08, 2023
Application Filed
Aug 25, 2026
Non-Final Rejection mailed — §101, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12744106
PROCESSES FOR CALCULATING PHASED FETAL GENOMIC SEQUENCES
4y 2m to grant Granted Sep 22, 2026
Patent 12744128
PREDICTIVE MODEL FOR DETERMINING CHANGES IN MOLECULAR STATE
1y 2m to grant Granted Sep 22, 2026
Patent 12716101
METHODS OF ASSESSING AND MONITORING TUMOR LOAD
4y 2m to grant Granted Aug 25, 2026
Patent 12712054
DIABETES ONSET AND PROGRESSION PREDICTION USING A COMPUTERIZED MODEL
3y 10m to grant Granted Aug 18, 2026
Patent 12694948
Bioinformatics Systems, Apparatuses, and Methods for Performing Secondary and/or Tertiary Processing
5y 5m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
87%
With Interview (+14.7%)
3y 11m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 840 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month